COVID-19 vaccine doses administered in India September 2022, by type
- statista.com
Updated Jul 12, 2023
Share
Facebook
Twitter
EmailClick to copy linkLink copiedCiteStatista (2023). COVID-19 vaccine doses administered in India September 2022, by type [Dataset]. https://www.statista.com/statistics/1248301/india-covid-19-vaccines-administered-by-vaccine-type/Dataset updatedJul 12, 2023Area coveredIndiaDescriptionOut of the two billion COVID-19 vaccines administered, over 1.6 billion vaccines were Covishield vaccine developed by Oxford university and AstraZeneca as of September 1, 2022 in India. Vaccinations in India were administered since January 16, 2021, with the administration of vaccines to all health care workers in the first phase. In February, the vaccination program was expanded to cover front line workers. The second phase of the program began in March which included citizens above the age of 60 and subsequently, people above the age of 45 with comorbidities. India’s vaccination program currently includes three vaccines, namely, Oxford University – AstraZeneca’s Covishield vaccine, manufactured by the Serum Institute of India, Bharat Biotech Covaxin and Russia's Sputnik V.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
FacebookTwitterEmailCOVID-19 vaccine doses administered in India September 2022, by type
Out of the two billion COVID-19 vaccines administered, over 1.6 billion vaccines were Covishield vaccine developed by Oxford university and AstraZeneca as of September 1, 2022 in India. Vaccinations in India were administered since January 16, 2021, with the administration of vaccines to all health care workers in the first phase. In February, the vaccination program was expanded to cover front line workers. The second phase of the program began in March which included citizens above the age of 60 and subsequently, people above the age of 45 with comorbidities. India’s vaccination program currently includes three vaccines, namely, Oxford University – AstraZeneca’s Covishield vaccine, manufactured by the Serum Institute of India, Bharat Biotech Covaxin and Russia's Sputnik V.